Categories
News

Cases of COVID-19 increases in Russia alongside vaccine production countries.

In Russia, 8.8 thousand cases of COVID-19 were detected per day.

Rostec estimated the terms of registration of its vaccine against COVID-19 and influenza.

The number of deaths of Russians with COVID-19 exceeded 200 thousand people.

(Face Of Nigeria Blog News)- While most part of Africa have recorded lower rates compared to their developed countries asides from the South Africa, cases of COVID-19 increases in Russia along-sides vaccine production countries like India , down to most part of Europe, could it be that people step down their guards on mask and social distance protective measures.

On April 21, Russian President Vladimir Putin, during the announcement of a message to the Federal Assembly, said that thanks to mass vaccination by the fall, the population of the country should form collective immunity from the COVID-19 coronavirus.

Over the past few days, the incidence rate of coronavirus has been at a stable level: less than 9 thousand infected people are detected daily in the country.

The last time more than 9 thousand cases were detected on April 17

Over the past day, 8228 cases of COVID-19 infection have been detected in Russia, including 1.1 thousand (13.1%) without clinical manifestations. This was reported at the operational headquarters.

The last time in the country, more than 9 thousand cases were detected on April 17.

Then the coronavirus was found in 9321 people. In the following days, less than 9 thousand people with COVID-19 were detected daily.

In total, since the beginning of the epidemic in Russia, 4.75 million have been infected with coronavirus, another 4.38 million have been cured. Over the past day, cases of infection were registered in 85 regions.

Most of the infected were found in Moscow (1879), St. Petersburg (1012), Moscow region (511), as well as in Lipetsk (262), Voronezh (213) and Nizhny Novgorod (211) regions.

Over the past 24 hours, 399 people have died in Russia due to COVID-19.

In total, since the beginning of the pandemic, according to the headquarters, 107.9 thousand people have died.

The data of the operational headquarters on deaths differ from the data of Rosstat, which only from last April to January 2021 counted 200 thousand deaths.

The difference is related to the calculation methodology: Rosstat includes in its statistics those who died from other diseases against the background of COVID-19, as well as those who were found to have the virus after death.

Earlier, Deputy Prime Minister Tatyana Golikova reported a significant increase in mortality in Russia in 2020 – by 18%, or 323.8 thousand people. Of these, the deaths with COVID-19 account for about half.

A significant proportion of excess mortality in the past year was formed by cases when people died from cardiovascular, endocrine diseases, pneumonia, etc., associated with infection with COVID-19.

Rostec estimated the terms of registration of its vaccine against COVID-19 and influenza.

In March, Natsimbio became the supplier of Sputnik V.

As explained in the Ministry of Health, she “has extensive experience in the supply of vaccines within the framework of the national vaccination schedule.” Previously, the vaccine logistics was handled by the Immunotechnology company, which is part of the Sberbank ecosystem.

According to the head of the state corporation, the single-phase drug should protect against both coronavirus and flu.

The company “Natsimbio”, which belongs to “Rostec”, announced the development of its own vaccine in March

Rostec has developed a comprehensive vaccine that should protect against COVID-19 coronavirus infection and influenza. This was announced by the head of the state corporation Sergei Chemezov in an interview with the Vesti on Saturday program on the Russia 1 TV channel .

According to Chemezov, the drug will be single-phase: “Instead of two injections, one can be given.”

The head of Rostec suggested that the vaccine will be registered before the end of this year or at the beginning of 2022.

Andrey Zagorsky, CEO of Rostec-owned Natsimbio holding, said that the company is working on its own vaccine against COVID-19 in mid-March. “We are developing a covid vaccine <…>, as we register, we will be the first to inform you about it,” he told the RBC TV channel.

On April 1, Rostec reported that the Ministry of Health registered a specific immunoglobulin drug developed by Natsimbio for the treatment of COVID-19, created on the basis of the blood plasma of those who had been ill.

Now in Russia there are three registered vaccines against coronavirus: “Sputnik V”, developed by the Moscow Center. Gamalei, “EpiVacCorona” from the Novosibirsk scientific center “Vector” and “KoviVak” from the Center named after Chumakov.